Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853)
Extramural Research Programs in the Neurosciences and Neurological Disorders (Assistance Listing 93.853) is run by the National Institutes of Health, part of the Department of Health and Human Services. It awarded $9.1 billion in 8,641 grants from fiscal 2021 to 2025, about $1.0 million per award on average. 104 funding opportunities are open or forecast now.
The typical award was $684,451. Half of the 8,639 awards fell between $270,000 and $1.6 million, and they ranged from $0 to $26.5 million.
- Awarded, FY 2021 to 2025$9.1 billion
- Grant awards8,641
- Typical award$684,451
- Awarded in FY 2025$1.8 billion
- Size rank56 of 1,823
- Type of assistanceProject grants
Key findings
- Annual funding was roughly flat, $1.8 billion in fiscal 2021 and $1.8 billion in fiscal 2025.
- It is the 56th largest of 1,823 federal grant programs by five-year awards.
- The 20 largest recipients received 40% of the money.
- Awards went to recipients in 52 states and territories.
What the program funds
(1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understand the causes and origins of pathological conditions of the nervous system with the goal of preventing these disorders; research on the natural course of neurological disorders; improved methods of disease prevention; new methods of diagnosis and treatment; drug development; development of neural devices; clinical trials; and research training in basic, translational and clinical neuroscience. The Institute is the largest funder of basic neuroscience in the US and supports research on topics including but not limited to: development of the nervous system, including neurogenesis and progenitor cell biology, signal transduction in development and plasticity, and programmed cell death; synapse formation, function, and plasticity; learning and memory; channels, transporters, and pumps; circuit formation and modulation; behavioral and cognitive neuroscience; sensorimotor learning, integration and executive function; neuroendocrine systems; sleep and circadian rhythms; and sensory and motor systems. In addition, the Institute supports basic, translational and clinical studies on a number of disorders of the nervous system including (but not limited to): stroke; traumatic injury to the brain, spinal cord and peripheral nervous system; neurodegenerative disorders; movement disorders; brain tumors; convulsive disorders; infectious disorders of the brain and nervous system; immune disorders of the brain and nervous system, including multiple sclerosis; disorders related to sleep; and pain. Programmatic areas, which are primarily supported by the Division of Neuroscience, are also supported by the Division of Extramural Activities, the Division of Translational Research, the Division of Clinical Research, the Office of Training and Workforce Development, the Office of Programs to Enhance the Neuroscience Workforce, and the Office of International Activities. (2) To expand and improve the Small Business Innovation Research (SBIR) program; to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. To utilize the Small Business Technology Transfer (STTR) program; to stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.
Open and forecast opportunities
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
- Translational Neural Devices (R61/R33 - Clinical Trial Optional)
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
Rules from the program listing
Who can apply
Research Grants: Any public, private, nonprofit, or for-profit institution is eligible to apply. For-profit institutions are not eligible for Institutional National Research Service Awards but are eligible for Individual NRSAs. All proposals are reviewed for scientific merit, for evaluation of the qualifications of the investigators, for adequacy of the research environment, and for significance of the problem. Approved proposals compete for available funds. All Career Development Program awardees, with the exception of awardees of the Pathway to Independence Award (K99/R00), must be citizens or have been admitted to the United States for permanent residence. Candidates must be nominated for the program by a nonfederal public or private nonprofit institution located in the United States, its possessions or territories. To be eligible, postdoctoral NRSA trainees or fellows must have a professional or scientific degree (M.D., Ph.D., D.D.S., D.O., D.V.M., Sc.D., D. Eng., or equivalent domestic or foreign degree). SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project.
What the money can and cannot pay for
Research grants may be used to provide salaries, equipment, supplies, travel and other expenses for research. The grantee institution is obliged to expend grant funds prudently for the purposes stated in the application and award document. National Research Service Awards (NRSAs) are made directly to individuals for research training in specified biomedical shortage areas, or to institutions, to enable them to make NRSAs to individuals selected by them. Each individual who receives a NRSA may be obligated upon termination of the award to comply with service and payback provisions. Career Development Awards such as the Independent Scientist Awards (K02) provide support for newly independent scientists with health-related degrees who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers and facilitating their ability to obtain major NIH research awards. Mentored Clinical Research Scientist Development Awards (K08) provide support for clinically trained health professionals who need an additional period of sponsored research experience as a way to gain expertise in a research area new to the candidate or in an area that would demonstrably enhance the candidate's scientific career.
Matching requirements
This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Award range and average, in the agency's words
Research grants: $22,709 to $7,753,905; $585,282. National Research Service Awards: Institutional $34,076 to $692,757; $193,304. Individual: $5,495 to $90,284; $46,239. SBIR/STTR: Phase 1 not to exceed $150,000; Phase II not to exceed $1,000,000; however with appropriate justification, budget caps for Phase I and Phase II are $225,000 and $1,500,00 respectively
Funding history and past recipients
From fiscal 2021 to 2025, Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $9.1 billion across 8,641 grant awards, an average of $1.0 million per award.
Who usually wins
Colleges and universities received 76% of the money, nonprofits 16% and small businesses 3.8%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Colleges and universities | 6,678 | $6.9 billion | 76% |
| Nonprofits | 1,317 | $1.5 billion | 16% |
| Small businesses | 305 | $345 million | 3.8% |
| Other | 323 | $303 million | 3.4% |
| Businesses | 5 | $8.9 million | 0.1% |
| State and local governments | 11 | $605,130 | less than 0.1% |
| Tribal governments and organizations | 2 | $200,000 | 0% |
By state
48 states have a page for this program: those that received at least $1 million or 10 awards.
| State | Awards | Amount |
|---|---|---|
| California | 1,281 | $1.4 billion |
| New York | 841 | $926 million |
| Massachusetts | 827 | $906 million |
| Pennsylvania | 627 | $626 million |
| Texas | 505 | $499 million |
| Maryland | 372 | $435 million |
| Ohio | 322 | $409 million |
| Illinois | 349 | $380 million |
| Michigan | 268 | $312 million |
| Florida | 227 | $282 million |
| Missouri | 234 | $250 million |
| Georgia | 254 | $230 million |
| North Carolina | 264 | $229 million |
| Connecticut | 216 | $226 million |
| Minnesota | 170 | $206 million |
| Virginia | 139 | $158 million |
| Washington | 150 | $150 million |
| Tennessee | 134 | $120 million |
| Wisconsin | 137 | $120 million |
| Colorado | 149 | $119 million |
| New Jersey | 126 | $106 million |
| Iowa | 79 | $101 million |
| Oregon | 117 | $96.1 million |
| Utah | 76 | $90.6 million |
| Indiana | 62 | $76.4 million |
| Alabama | 91 | $75.3 million |
| District of Columbia | 77 | $73.5 million |
| Arizona | 59 | $65.1 million |
| Kentucky | 59 | $55.6 million |
| Rhode Island | 105 | $48.8 million |
| South Carolina | 49 | $38.1 million |
| Nebraska | 30 | $35.4 million |
| Louisiana | 34 | $27.9 million |
| New Mexico | 21 | $25.5 million |
| New Hampshire | 24 | $24.2 million |
| Maine | 22 | $21.7 million |
| Kansas | 16 | $17.2 million |
| Nevada | 18 | $15.9 million |
| Oklahoma | 8 | $10.8 million |
| Vermont | 15 | $7.5 million |
| Puerto Rico | 13 | $7.2 million |
| West Virginia | 8 | $5.5 million |
| Montana | 6 | $4.0 million |
| Delaware | 11 | $3.7 million |
| Arkansas | 8 | $3.5 million |
| North Dakota | 3 | $3.2 million |
| Idaho | 2 | $1.5 million |
| Wyoming | 2 | $1.4 million |
| Hawaii | 3 | $623,595 |
| Alaska | 1 | $414,812 |
| Mississippi | 4 | $242,345 |
| South Dakota | 1 | $11,525 |